LETKO, BROSSEAU & ASSOCIATES INC Q4 2021 Filing

Filed February 9, 2022

Portfolio Value

$7.0B

Holdings

107

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (107 positions)

#StockSharesValue% PortfolioType
101
ATRAGBXATARA BIOTHERAPEUTICS INC
15,700$247.0M3.54%
102
MSFTMICROSOFT CORP
638$215.0M3.08%
103
IMV1EURIMV INC
170,000$210.0M3.01%
104
ARDXARDELYX INC
172,300$190.0M2.72%
105
MEDICENNA THERAPEUTICS CORP
100,000$163.0M2.33%
106
ONCORUS INC
24,750$130.0M1.86%
107
BCELATRECA INC
17,800$54.0M0.77%
PreviousPage 2 of 2